Latest news with #IsraelInnovationAuthority
Economic Times
20-07-2025
- Business
- Economic Times
New high tech incubators to get millions in funding
Tired of too many ads? Remove Ads The Israel Innovation Authority (IIA) launched a competitive proceeding to establish new high-tech incubators with up to a 40 million Shekel (USD 11.9 million) investment per part of the IAA's program, funding will be provided to cover management fees over a five-year period and the establishment of a central Incubators will focus on high-risk, innovation-intensive Deep-Tech fields such as: semiconductors , bio-convergence, agri-food tech , robotics, defence tech, or other domains characterised by high technological complexity, significant risk, and a lack of specialised investors in addition, the Authority will also offer non-dilutive investments from the Startup Fund at a total of approximately 100 million Shekels (USD 29 million) over the course of the franchise period, as well as providing support that will enable startups incubated within the program to receive grants of up to 21 million Shekels, from Pre-Seed stage through Round A financing.
Time of India
20-07-2025
- Business
- Time of India
New high tech incubators to get millions in funding
Tired of too many ads? Remove Ads The Israel Innovation Authority (IIA) launched a competitive proceeding to establish new high-tech incubators with up to a 40 million Shekel (USD 11.9 million) investment per part of the IAA's program, funding will be provided to cover management fees over a five-year period and the establishment of a central Incubators will focus on high-risk, innovation-intensive Deep-Tech fields such as: semiconductors , bio-convergence, agri-food tech , robotics, defence tech, or other domains characterised by high technological complexity, significant risk, and a lack of specialised investors in addition, the Authority will also offer non-dilutive investments from the Startup Fund at a total of approximately 100 million Shekels (USD 29 million) over the course of the franchise period, as well as providing support that will enable startups incubated within the program to receive grants of up to 21 million Shekels, from Pre-Seed stage through Round A financing.
Associated Press
09-04-2025
- Business
- Associated Press
Israel Innovation Authority Picks Deep Tech Incubators to Launch Startups with 5-year Investment of Hundreds of Millions
New incubators to drive innovation in energy, infrastructure, and medical technology —shaping the next wave of Israeli deep tech success stories JERUSALEM, ISRAEL, April 9, 2025 / / -- The Israel Innovation Authority announced today the selection of two new technology incubators—Square One Labs Build and Edge Medical Ventures— to establish, invest in, and support dozens of Deep Tech startups in Israel as part of an innovative Venture Creation & Building Studio model. Each incubator will receive a total budget of up to NIS 40 million over five years and will independently invest tens of millions of dollars in startups within their respective fields. The incubators are expected to establish and grow dozens of groundbreaking companies in areas such as energy, industry, data center infrastructure, medical devices, and Bio-convergence—the integration of technological, biological, and engineering domains. Gila Gamliel, Minister of Innovation, Science and Technology: 'The new incubators, backed by investments of hundreds of millions of shekels, position Israel at the forefront of global Deep Tech. The innovative model we've created connects public and private capital, significantly shortens the path from idea to global product, and strengthens our economic and security resilience. Accelerating the pace of innovation during such a challenging time is a clear expression of the determination and strength of the Israeli economy.' Dr. Alon Stopel, Chairman of the Israel Innovation Authority: 'This is a groundbreaking strategic move, based on insights and experience accumulated over years of operating previous incubator programs in Israel, combined with lessons learned from advanced global models—particularly from the United States. The process of designing the new program took many months and included precise adaptation to the evolving reality of the Israeli high-tech sector. The tender's outcome announced today reflects our vision for incubators that operate as entrepreneurial accelerators—composed of corporations, VC funds, entrepreneurs, and academics—providing founders with a full support system—technological, business, and financial—from the earliest stages. We see this as another significant step in building a strong Israeli Deep Tech industry that will tackle the major engineering challenges of the next decade, including energy, sophisticated infrastructure, medical devices, and more. In the future, we will consider expanding into areas such as semiconductors and additional technologies.' Dror Bin, CEO of the Israel Innovation Authority: 'We are proud to announce today the results of one of the most significant initiatives to advance the Deep Tech sector in Israel. This was a rigorous, highly qualitative, and competitive process that attracted outstanding proposals from top-tier Israeli and international players—including industrial entities, investment funds, medical institutions, and academic leaders—who joined forces to build the next generation of breakthrough startups. The selected incubators will serve as active creation engines, enabling the establishment of innovative companies from ideation or early research stage and supporting them throughout all stages of development—from inception to market entry and global growth. This model not only reduces the risk for entrepreneurs but also provides them with everything they need to truly succeed—access to advanced laboratories, strategic partnerships, expertise from leading institutions, and substantial government investment. We believe in the power of Deep Tech to be a game-changer in fields such as health, infrastructure, energy, and science—and the platforms selected today will serve as the launchpad for the next great Israeli success stories.' The incubators were selected through a new competitive process launched in 2024, parallel to the establishment of a Startup Fund that enables the Authority to participate in funding rounds of Israeli Deep Tech companies from ideation all the way to Round A funding —without taking equity or diluting the founders. The new model emphasizes deep and broad investment—covering business, regulatory, technological, and financial aspects intending to build companies rooted in real needs and with the potential to break into global markets. Square One Labs Build – Incubator for Energy, Industry, and Data Center Infrastructure Square One Labs Build was selected to establish a Venture Creation incubator in the critical fields of energy, advanced industry, and infrastructure for data centers. The incubator was formed as a consortium with a synergy of leading corporations, including Doral Energy-Tech Ventures, Afcon Control & Automation, RAD Group, Bazan Group, Square One Fund, Enlight's Elements Fund, and academic and business partners. The incubator will establish companies using an Entrepreneur in Residence model, where entrepreneurs develop solutions for problems defined or validated by strategic partners. To support this, a network of four specialized labs will be established in key fields: materials science, power electronics, thermodynamics, and robotics. The leadership team includes top industry figures Amir Fishlov and Yoav Galin (co-founders of SolarEdge), Yonatan Bik (CTO), and Miki Hefetz (VP of Business Development). Edge Medical Ventures – Incubator Specializing in Medical Devices and Bio-convergence Edge Medical Ventures will establish a cutting-edge incubator focused on medical devices, emphasizing Deep Tech and interdisciplinary solutions that combine hardware, software, biology, and materials engineering. Partners in the incubator include Boston Scientific, one of the world's largest medical device companies; the investment funds Edge Medical Partners and Issec Capital (CBG); Hadassah, Sheba, and Wolfson medical centers; Cornell University Medical Center; and Hadasit, Hadassah University Medical Center's technology transfer and innovation company. The incubator team developed a comprehensive Venture Creation methodology, including defining clinical needs in collaboration with strategic partners, deep market and competition validation, and commercializing knowledge from leading medical institutions in Israel and abroad. The companies established will benefit from one of the most advanced testing infrastructures in Israel, including a prototype development lab, in-vivo testing, early-stage manufacturing capabilities, validation and regulatory support for FDA submissions, and more. Edge Medical is built on proven experience - MEDX, its previous incubator, launched in 2017 has established 20 companies, of which 13 have raised approximately $50 million from the private market. The leadership team includes Shay Poliker (CEO), Gal Atarot (CTO), Noam Teichler (CFO), and Eileen Kee (VP of Commercialization). A New Investment Model: A Unique Blend of Public and Private Funding Formulated in 2024, the new model encourages the proactive creation of Deep Tech companies by leveraging institutional and industrial knowledge, with significant early-stage involvement by the Innovation Authority. The model is tailored to the needs of Deep Tech ventures, which require significant investment and long maturation periods—unlike classic tech startups. The Innovation Authority will act as a strategic partner without taking equity, based on excellence and a thorough evaluation of each investment. Key model highlights: - Up to NIS 40 million in cumulative grants per incubator, including management fees, setup expenses, and lab infrastructure - Minimum private sector investment requirement: NIS 120 million - Innovation Authority participation in funding rounds without equity dilution - Opportunity for additional VC and CVC participation - LP/GP structure allowing for additional capital funding rounds (Second Closing) after selection Raoul Wootliff N10S 546921720398
Associated Press
29-01-2025
- Business
- Associated Press
Israel Innovation Authority Invests ₪75M to Establish Groundbreaking R&D Lab for Bio-Devices and Bio-Chips
Innovative bio-convergence lab to propel Israel as a global leader in smart medical diagnostics, environmental restoration, and sustainable energy generation JERUSALEM, ISRAEL, January 29, 2025 / / -- The Israel Innovation Authority announced today a landmark investment of ₪113 million to establish Israel's first laboratory dedicated to bio-devices and bio-chips. This initiative, led by Israel Aerospace Industries (IAI) and Baccaramos Technologies, aims to position Israel at the forefront of global innovation by developing advanced technologies such as intelligent medical implants, smart environmental sensors, and bio-based energy solutions. Integrating biology, engineering, and artificial intelligence, the lab will serve as a critical growth engine for Israel's biotech sector, offering unparalleled R&D services to drive innovation across multiple industries. This is a strategic breakthrough aimed at placing Israel at the heart of the global technological landscape. The new laboratory will provide unique R&D services across numerous sectors, enabling Israeli researchers and companies to compete internationally, and will also serve as a significant growth engine for Israel's local bio-tech industry. Dror Bin, CEO of the Israel Innovation Authority: 'This initiative will solidify Israel's global standing. As part of the broader vision outlined in the National Bio-Convergence Plan, this new lab will establish Israel as a global leader in the field. This partnership will equip Israeli companies with the advanced tools and infrastructure needed to pioneer bio-chip and bio-device projects locally – in medicine, energy and agriculture - from concept to reality, without reliance on costly international services. The lab is expected to serve as a hub of knowledge, research, and development, attracting foreign investment, fostering international collaborations, and drawing top talent to Israel. This lab isn't just an investment in infrastructure – it's an investment in our future and reflects the Israel Innovation Authority's commitment to diversifying and growing Israel's high-tech sector, even amid increasing global competition.' While primarily associated with healthcare, bio-devices are now demonstrating utility across energy, environment, water, agriculture, and security sectors. For example, bio-devices that generate electricity from biological processes make it easier and cheaper to produce power from waste. Devices can release bacteria that break down organic materials via cellular respiration, simultaneously purifying contaminated water and generating electricity. Vision in Action: Collaboration Between Innovation Leaders Following a rigorous selection process, the partnership between Israel Aerospace Industries and Baccaramos Technologies was chosen to lead the establishment of the lab: • Israel Aerospace Industries (IAI) is a global leader in developing advanced technologies across diverse sectors, providing innovative systems to customers in over 100 countries. IAI boasts expertise in 3D printing, advanced materials, machine learning, simulation, and multidisciplinary system integration. • Baccaramos Technologies, based in Caesarea and established in 1998, provides advanced packaging solutions for chips and optical components. The company operates state-of-the-art cleanrooms and chip assembly equipment, and offers design, manufacturing, failure analysis, and consultancy services in the fields of chip assembly, devices and optic components, amongst others. Baccaramos has an expert staff, with vast experience working with hundreds of companies in Israel and worldwide, including R&D companies in the field of bio-convergence. In addition to the extensive and proven experience of IAI and Baccaramos in the field of technology and engineering, the collaboration will also leverage the expertise of domestic and international partners in biology including Fraunhofer IGB and Ginkgo Bioworks, as well as NVIDIA in the field of computing and AI, NY CREATES in the field of chip manufacturing, and others. A Game-Changing Laboratory The bio-chip and bio-device lab will offer Israeli companies access to world-class technological infrastructure and advanced R&D services, including prototyping, small-scale production, and validation. The technologies developed in the lab are expected to accelerate drug development, diagnostics and monitoring, and to make biological production processes cheaper, more exact, and more accessible. Bio-chips and bio-devices serve as essential tools to revolutionize diagnostics, detection, and monitoring across humans, animals, plants, water, air, and soil. The ability to manipulate individual cells within a bio-chip (using a process known as microfluidics) to perform biological processes in microscopic volumes and measure changes with molecular sensitivity through nanotechnology essentially 'condenses' into a small chip what has, for decades, required large, expensive biological labs. Bio-convergence integrates biological science with engineering, software, and computational technologies. This emerging field is poised grow rapidly and to transform fields such as medicine, environment, energy, agriculture, food, security, and more. Examples of Potential Developments in the Lab: 1. Purifying Contaminated Water: Smart devices combining advanced bacteria to clean water while generating electrical energy through cellular respiration. 2. Air Pollution Monitoring: Bio-chips detecting molecular-level toxins in real-time, enabling urban and industrial air restoration. 3. Marine Environmental Restoration: Biological devices breaking down organic and plastic waste in oceans, purifying water, and generating energy. 4. Rapid Infectious Disease Diagnosis: Smart chips diagnosing viral or bacterial diseases within minutes from small samples, providing immediate, personalized treatment recommendations. 5. Autonomous Biological Security Systems: Devices detecting explosives or hazardous materials at border crossings with tailored neutralizing responses. 6. Smart Food Production: Biological technologies enabling sustainable food growth in harsh conditions while minimizing waste and preserving nutritional value. 7. Toxic Material Cleanup: Sensors designed to identify and rehabilitate areas contaminated by toxic substances in water or soil through precise biological reactions. 8. Early Public Health Monitoring: Urban sensors detecting early outbreaks of infectious diseases and preventing epidemics. N10S 546921720398
